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Summary. Introduction: Smoothelin is a cytoskeletal
protein of differentiated smooth muscle cells with
contractile capacity, distinguishing it from other smooth
muscle proteins, such as smooth muscle actin (SMA). 
Objective: To evaluate the expression of smoothelin
and SMA in the skin in order to establish specific
localizations of smoothelin in smooth muscle cells with
high contractile capacity and in the epithelial component
of cutaneous adnexal structures. Methods:
Immunohistochemical analysis (smoothelin and SMA)
was performed in 18 patients with normal skin.
Results: SMA was expressed by the vascular
structures of superficial, deep, intermediate and
adventitial plexuses, whereas smoothelin was
specifically expressed in the cytoplasm of smooth
muscle cells of the deepest vascular plexus and in no
other plexus of the dermis. The hair erector muscle
showed intense expression of smoothelin and SMA.
Cells with nuclear expression of smoothelin and
cytoplasmic expression of SMA were observed in the
outer root sheath of the inferior portion of the hair
follicles and intense cytoplasmic expression in cells of
the dermal sheath to SMA. 
Conclusions: We report the first study of smoothelin
expression in normal skin, which differentiates the
superficial vascular plexus from the deep. The deep
plexus comprises vessels with high contractile capacity,
which is important for understanding dermal
hemodynamics in normal skin and pathological
processes. We suggest that the function of smoothelin in
the outer root sheath may be to enhance the function of
SMA, which has been related to mechanical stress.
Smoothelin has not been studied in cutaneous pathology;
however we believe it may be a marker specific for the
diagnosis of leiomyomas and leiomyosarcomas of the
skin. Also, smoothelin could differentiate arteriovenous
malformations of cavernous hemangioma of the skin.
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Introduction
Smoothelin has two tissue-specific isoforms: the
short 59-kDa isoform (A), found in smooth muscle cells
of the organs; and the long 110-kDa isoform (B), in
smooth muscle cells of vascular structures (Krämer et
al., 2001; Rensen et al., 2002). Smoothelin contains an
actin-binding domain and is considered to be a
cytoskeleton protein exclusively expressed by
differentiated smooth muscle cells with contractile
capacity (Krämer et al., 1999, 2001). 
Different grades of differentiation of muscle cells in
vessels are determinated by expression of phenotypic
features such as smoothelin, myosin and actin of smooth
muscle. Depending on the grade of differentiation of
these cells, vessels have an important role in physiologic
processes, such as thermoregulation with vaso-
constriction and vasodilatation as a response to
environmental temperature changes, and in
physiopathologic processes such as atherogenesis and
restenosis after angioplasty and other surgical techniques
(Holifield et al., 1996; Hungerford and Little, 1999), as
well as Raynaud phenomenon and erythromelalgia: two
cutaneous microvascular disorders whose
pathophysiological features are poorly understood
(Greenstein et al., 1995; Davis et al., 2000).
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Histopathology
Cellular and Molecular Biology
Immunohistochemical studies have detected
smoothelin expression in smooth muscle cells of the
esophagus, stomach, gut, prostate, uterus, and bladder,
and in leiomyoma, leiomyosarcomas, and gastro-
intestinal stromal tumors (Van der Loop et al., 1996;
Council and Hameed, 2000; Niessen et al., 2005; Wedel
et al., 2006; Amiot et al., 2009; Coco et al., 2009; Bovio
et al., 2010). We have found only one published study on
the cell localization of smoothelin expression, which
evaluated its cytoplasmatic and nuclear expression in
normal and tumor smooth muscle cells (Coco et al.,
2009).
The objective of this study was to investigate the
expression of smoothelin and smooth muscle actin
(SMA) in the skin in order to establish specific
localizations of smoothelin in smooth muscle cells with
high contractile capacity and in the epithelial component
of cutaneous adnexal structures. 
Materials and methods
Patient samples
We studied 18 biopsies of normal skin that included
the epidermis, dermis, and part of the hypodermis. They
derived from flaps removed for grafting purposes from
the limb or scalp of 10 females and 8 males aged
between 25 and 48 yrs. Written informed consent was
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Fig. 1. A. Smoothelin expression is positive only in the vessel walls of deep plexus (DP), with no expression in the superficial plexus (SP). Some
vessels of the intermediate plexus (IP) are also positive for smoothelin. Intense expression is found on hair erector muscle (Red arrow), however ecrine
sweat glands shows no expression (Green arrow). B. On higher magnification, vessels of SP are negative for smoothelin. C. Vessel walls of DP are
positive for smoothelin. A, x 100; B, x 200; C, x 400
obtained from all subjects.
Immunohistochemical analysis
Samples were fixed in 10% buffered formalin for 24
hrs and embedded in paraffin. Paraffin-embedded 4-μm
sections were dewaxed, hydrated, and heat-treated at
95°C for 20 min in 1 mM EDTA buffer pH 8 for
antigenic unmasking. Sections were incubated for 30
min at room temperature with smoothelin (prediluted
monoclonal antibody, clone R4A) or SMA (prediluted
clone 1A4) (Master Diagnóstica, Granada, Spain). The
immunohistochemical study was done on an automatic
immunostainer (Autostainer 480, LabVision Fremont,
CA) by indirect polymer-peroxidase-based method
followed by development with diaminobenzidine
(Masvision, Master Diagnóstica). The intensity of
cytoplasmic and/or nuclear expression was graded as
weak, moderate, or strong. 
Results
Smoothelin and SMA expression in the vascular
structures of the dermis and dermal-hypodermal
interface, comprising superficial, deep, intermediate
(communicating vessels), and adventitial plexuses
All biopsies showed intense cytoplasmic expression
of smoothelin in smooth muscle cells of arteries and
moderate cytoplasmic expression in veins of the deep
vascular plexus at the dermal-hypodermal interface. No
expression was found in superficial or adventitial
plexuses (Fig. 1).
All biopsies showed intense SMA expression in the
vessel walls of deep, intermediate, superficial, and
adventitial plexuses (Fig. 2).
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Fig. 2. A. Smooth muscle actin expression is noted in the vessel walls of deep plexus (DP), intermediate plexus (IP) and superficial plexus (SP).
Intense expression is found on hair erector muscle (Arrows). B. On higher magnification, IP and SP show intense expression for smooth muscle actin.
C. Vessels on the DP are positive for smooth muscle actin (Arrows). A, x 100; B, C, x 200
Smoothelin and SMA expression in hair erector muscle
All biopsies showed intense cytoplasmic expression
of smoothelin and SMA in smooth muscle cells of the
hair erector muscle (Figs. 1A, 2A).
Smoothelin and SMA expression in hair follicle 
All biopsies showed moderate cytoplasmic
expression of SMA in cells of the inferior portion of the
outer root sheath and intense cytoplasmic expression in
cells of the dermal sheath (Fig. 3).
An intense nuclear expression of smoothelin was
found in some cells of the inferior portion of the outer
root sheath of all hair follicles in anagen (Fig. 4), while
no expression was observed in the remaining layers of
the hair structure.
Smoothelin and SMA expression in sweat glands
(eccrine and apocrine) and sebaceous glands
No smoothelin expression was detected in sweat or
sebaceous glands (Fig. 1A). 
In all biopsies, an intense cytoplasmic expression of
SMA was found in myoepithelial cells of the secretory
portion of eccrine and apocrine glands (Fig. 2A), while
no SMA expression was detected in the excretory
portion or sebaceous glands.
No smoothelin or SMA expression was detected in
other components, such as epidermis, dermal fibroblasts,
hypodermal adipocytes, or nerve fibers.
Discussion
This study of normal skin biopsies found a higher
expression of smoothelin in cells of the hair erector
muscle than in muscle cells of deep plexus veins,
reflecting the elevated contractile capacity of the hair
erector muscle and suggesting that it may serve as a
good positive control in smoothelin assays. An important
finding was that SMA was identified all vascular
structures of the dermal plexuses, but smoothelin
expression allowed differentiation of the deep vascular
plexus from the other structures, which may facilitate
research into the homodynamic of the cutaneous
structure normal and pathological dermatological
processes, such as dermatitis, stasis, alterations caused
by heat and cold which can present vasodilation and / or
vasoconstriction. We also believe that smoothelin may
help to understand the pathophysiological mechanisms
involved in the different stages of rosacea. Thus the
assessed value of smoothelin could help explain the
vascular changes that occur in different processes in
rosacea. Most blood vessels in the middle and superficial
dermis have no substantial contractile capacity and
showed no smoothelin expression.
Smoothelin expression in cutaneous vascular
tumours has not been studied previously, although there
is a work about the differential expression of smoothelin
in brain vascular lesions, in which a positive expression
in arteriovenous malformations and a negative
expression in cavernous hemangioma were
demomstrated (Uranishi et al., 2001). Since smoothelin
is expressed in well-differenciated muscle cells with
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Fig. 4. Nuclear expression of smoothelin is noted in the cells of the
outer radicular sheath (red arrows). x 400
Fig. 3. Smooth muscle actin expression is positive in the dermal sheath
(green arrows) and in the bottom area of the outer radicular sheath (red
arrows). x 200
contractile capacity from the deep vascular plexus, we
think this expression can be used to distinguish
arteriovenous malformations which consist of
malformed vessels with thick walls, and muscle cells
with contractile capacity which are smoothelin-positive.
However, no well-differenciated muscle cells can be
found in cavernous hemangioma, therefore these lesions
are negative for smoothelin.
SMA expression in cells of the hair follicle dermal
sheath cells has been implicated in contractile processes
that may control hair follicle shortening (Thibaut et al.,
2005), and play a role in curly hair follicle morphology.
Cytoplasmic expression of SMA in cells of the outer
root sheath has been related to stress mechanisms
(Baltenneck et al., 2000; Thibaut et al., 2005). We report
for the first time the nuclear expression of smoothelin in
some cells of the outer root sheath. The only published
report on the nuclear and cytoplasmic expression of
smoothelin in (normal and tumor) smooth muscle cells
offered no explanation of its nuclear expression (Coco et
al., 2009). The nuclear expression of smoothelin in the
hair outer root sheath can be helpful in the diagnosis of
skin adnexal tumors whose origin is the outer root
sheath, such as trichilemmoma and inverted follicular
keratosis (Kurokawa et al., 2003).
Smoothelin isoforms are homologous with other
cytoskeletal smooth muscle proteins and contain an
actin-binding domain. Treatment of cells with α-
amanitin induced the formation of an actin bundle
network in the nucleus (Baltenneck et al., 2000; Zhu et
al., 2004), and it is known that some types of stress (e.g.,
heart shock and dimethylsulfoxide treatment) can induce
the nuclear translocation of actin in various eukaryotic
cells (Iida et al., 1992; Wada et al., 1998). Hence, the
nuclear expression of smoothelin may be attributable to
a translocation mechanism, especially in tumor disease
(e.g., leiomyosarcoma, lymphoma) (Abd et al., 2007;
Coco et al., 2009). Based on these data, it can be
proposed that smoothelin may act to enhance the role of
SMA in the hair follicle. 
In the present study, the nuclear expression of
smoothelin and the cytoplasmic expression of SMA in
epithelial cells of the hair follicle outer root sheath may
be related to multipotential cell elements, which would
explain the expression of the two muscle markers. It has
long been known that the multipotent capacity of
epithelial cells of the follicle outer root sheath affords
them a critical role in the regeneration of damaged
interfollicular epidermis (Jahoda et al., 1993), explaining
the expression of a muscle marker in the outer epithelial
sheath of the follicle. Likewise, epithelial-mesenchymal
interaction is essential for hair follicle development
(Tobin et al., 2003a,b). Various studies have reported the
multipotent capacity of epithelial and mesenchymal
cells, demonstrating that cells of the dermal papilla and
outer hair follicle dermal sheath can differentiate into
adipocytes and express bone differentiation markers
such as alkaline phosphatase (Jahoda et al., 2003;
McElwee et al., 2003). Multipotent stem cells have been
described in the outer root sheath (Webb et al., 2004;
Raposio et al., 2007), which under certain circumstances
may give rise to epithelial cells that express smoothelin
and SMA. 
Smoothelin is expressed in non-cutaneous muscle
tumors (Coco et al., 2009), and in our study the hair
erector muscle and the walls of vessels from the deep
vascular plexus are smoothelin-positive, therefore this
expression can be implemented in the diagnosis of
benign and malignant muscle tumors of the skin, e.g.
leiomyoma and leiomyosarcomas.
This is the first report of the positive expression of
smoothelin in the outer root sheath of the hair follicle
and its possible functional link to SMA. Moreover,
smoothelin allows the deep vascular plexus to be
distinguished from remaining vascular structures of the
dermis. 
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